In Toronto, Ontario on June 22, 2026, COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) revealed its plans regarding alterations to its share capital. The company, also known as COSCIENS, provided details about the Share Capital Amendment.